HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Deals

Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics

Roche is set to pay out a little more than $1 billion to acquire digital pathology specialist Path AI in a move the pharma giant hopes will bolster the use of artificial intelligence in diagnostic algorithms.

By FierceBiotech · May 8, 2026 · via FierceBiotech
Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics

Image: FierceBiotech

This is an aggregated industry headline. Read the full story at FierceBiotech →

Tags
dealsformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Deals
All Deals →
Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
DealsFiercePharma ↗
Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalys…
May 8, 2026
GSK pens $1B deal with China’s SiranBio for oligonucleotide that could reduce abdominal fat
DealsFierceBiotech ↗
GSK pens $1B deal with China’s SiranBio for oligonucleotide that could reduce abdominal fat
GSK has found another potential way to treat cardiometabolic disease with a modality close to the pharma’s hea…
May 7, 2026
Bayer Buys Perfuse for $2.4B, Targeting Next-Generation Eye Disease Therapy
DealsBriefing
Bayer Buys Perfuse for $2.4B, Targeting Next-Generation Eye Disease Therapy
The $300M upfront deal gives Bayer control of PER-001, a midphase implant for glaucoma and diabetic retinopath…
May 7, 2026